Wine Tasting Raises Over $2200 for Multiple Sclerosis Research Organization

For Immediate Release
For more information contact:
Trish Gannon
Feinstein Kean Healthcare
Wine Tasting Raises Over $2200 for Multiple Sclerosis Research Organization
(October 20, 2005) - CINCINNATI - Glasses were raised as well as funds at the inaugural event of the Greater Cincinnati Cure Project, a volunteer run Expansion Team of the Accelerated Cure Project for Multiple Sclerosis, to fund research into the causes of Multiple Sclerosis. The evening of wine tasting and silent auction bidding raised over $2,200, which will be donated in its entirety to Accelerated Cure Project.
Eleanora Fusco and Ingo Kiesewetter welcomed over 35 individuals to their home in Columbia Tusculum, where wine tasting stations, homemade lasagnas and fondues were enjoyed from their decks and gracious living areas. A silent auction of wine lots and handcrafted jewelry by local artists contributed to the fun and fundraising.
"What a tremendous kick-off for our new MS fundraising group here in Cincinnati," said Jodi Supinski, a founding member of the Greater Cincinnati Cure Project and event organizer. "We are grateful for the generosity of those who attended and confident the dollars raised will go a long way in finding a cure for this debilitating disease."
The Greater Cincinnati Cure Project is the first Midwest Expansion Team of the Accelerated Cure Project, a national nonprofit dedicated to curing MS by determining its causes. The Cincinnati chapter is an important arm of the Accelerated Cure Project as the Cincinnati region seems to have a high incidence of Multiple Sclerosis and can be an important site for both fundraising and research by the Accelerated Cure Project.
"We plan to hold 2-3 events in Cincinnati each year that will raise money for the Accelerated Cure Project's efforts and also awareness about the innovative approach this organization is taking to develop a cure for MS," said Kemp Jaycox, a founding member of the Greater Cincinnati Cure Project.
For more information about the Greater Cincinnati Cure Project, or to get involved with its next local event, contact Kemp Jaycox at 513-300-7745 or For more information about Accelerated Cure Project, call 781-487-0008 or visit
About Accelerated Cure Project
Accelerated Cure Project for MS (ACP) is a nonprofit organization whose mission is to accelerate efforts toward a cure for multiple sclerosis (MS) by rapidly advancing research that determines its causes and mechanisms. We provide biomedical researchers with resources that catalyze open scientific collaboration and enable them to explore their novel research ideas rapidly and cost-efficiently. ACP’s strategic initiatives include the Multiple Sclerosis Discovery Forum and the ACP Repository, a large-scale collection of highly-characterized biosamples available to scientists at any organization conducting research that contributes to our mission. All results generated through analysis of Repository samples and data are contributed back to the ACP Repository Database, resulting in an increasingly valuable and comprehensive information resource that can be analyzed to reveal new insights about MS. To date, ACP has enrolled almost 3,000 participants into the Repository through a network of 10 MS clinical centers across the United States. The samples provided by people with MS and related disorders have supported more than 60 research studies worldwide and generated more than 150 million returned data points.
For more information about the Accelerated Cure Project or to make a corporate or individual donation, visit, or send an email to
About Multiple Sclerosis
Multiple Sclerosis is a chronic demyelinating disorder of the central nervous system that often results in severe disability including the inability to walk, blindness, cognitive dysfunction, extreme fatigue, and other serious symptoms. MS affects more than 400,000 people in the US and two million individuals worldwide. The disorder occurs twice as often in women as in men. What causes MS is undetermined and no cure has yet been developed.